Last updated on: 6/1/2009 | Author:

Richard Pazdur, MD Biography

Director of the Division of Oncology Drug Products at the US Food & Drug Administration
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"

“Dr. Pazdur has no opinion [on medical marijuana].”

Email from Richard Pazdur’s office, June 21, 2005

Theoretical Expertise Ranking:
     Key Experts
Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
  • Director, Division of Oncology Drug Products, US Food & Drug Administration, 1999-present
  • Member, American Society of Clinical Oncology
  • Professor of Medicine and Director of Educational Programs, University of Texas MD Anderson Cancer Center, Houston, TX, 1988-1999
  • MD, Loyola University of Chicago Stritch School Of Medicine
  • Northwestern University, Evanston, IL
  • Specialty is Medical Oncology